AirSPACE™ device for real-time positioning during laryngoscopy

AirSPACE™ device for real-time positioning during laryngoscopy

Accepted Manuscript AirSPACE™ device for real-time positioning during laryngoscopy Tyrone Burnett, Jr., Omar L. Mancillas, Chunyan Cai, Semhar Ghebrem...

3MB Sizes 2 Downloads 34 Views

Accepted Manuscript AirSPACE™ device for real-time positioning during laryngoscopy Tyrone Burnett, Jr., Omar L. Mancillas, Chunyan Cai, Semhar Ghebremichael, Sam D. Gumbert, Naveen Vanga, Carin A. Hagberg PII:

S2210-8440(17)30116-8

DOI:

10.1016/j.tacc.2017.06.004

Reference:

TACC 354

To appear in:

Trends in Anaesthesia and Critical Care

Received Date: 24 March 2017 Revised Date:

20 May 2017

Accepted Date: 27 June 2017

Please cite this article as: Burnett Jr. T, Mancillas OL, Cai C, Ghebremichael S, Gumbert SD, Vanga N, Hagberg CA, AirSPACE™ device for real-time positioning during laryngoscopy, Trends in Anaesthesia and Critical Care (2017), doi: 10.1016/j.tacc.2017.06.004. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT 1 1

AirSPACE™ Device for Real-Time Positioning During Laryngoscopy

2

Tyrone Burnett Jr. (BS)†a, Omar L. Mancillas (MD)†a, Chunyan Cai (PhD)†b, Semhar Ghebremichael (MD)†a,

4

Sam D. Gumbert (MD)†a, Naveen Vanga (MD)†a, Carin A. Hagberg (MD)*a

RI PT

3

5 6

†a

7

Houston (UTHealth) McGovern Medical School, 6431 Fannin St., MSB 5.020, Houston, Texas, 77030, U.S.A.,

8

E-mail: [email protected]

SC

Research Assistant II, Department of Anesthesiology, The University of Texas Health Science Center at

9 10

†a

11

Houston (UTHealth) McGovern Medical School, 6431 Fannin St., MSB 5.020, Houston, Texas, 77030, U.S.A.,

12

E-mail: [email protected]

13

M AN U

Research Assistant I, Department of Anesthesiology, The University of Texas Health Science Center at

14

†b

15

Houston (UTHealth) McGovern Medical School, 6410 Fannin St., UPB 1100.08, Houston, Texas, 77030,

16

U.S.A., E-mail: [email protected]

17

EP

TE D

Assistant Professor, Department of Internal Medicine, The University of Texas Health Science Center at

18

†a

19

Houston (UTHealth) McGovern Medical School, 6431 Fannin St., MSB 5.020, Houston, Texas, 77030, U.S.A.,

20

E-mail: [email protected]

AC C

Assistant Professor, Department of Anesthesiology, The University of Texas Health Science Center at

21 22

†a

23

Houston (UTHealth) McGovern Medical School, 6431 Fannin St., MSB 5.020, Houston, Texas, 77030, U.S.A.,

24

E-mail: [email protected]

25

Associate Professor, Department of Anesthesiology, The University of Texas Health Science Center at

ACCEPTED MANUSCRIPT 2

26

†a

27

Houston (UTHealth) McGovern Medical School, 6431 Fannin St., MSB 5.020, Houston, Texas, 77030, U.S.A.,

28

E-mail: [email protected]

Assistant Professor, Department of Anesthesiology, The University of Texas Health Science Center at

29 *a

31

Center at Houston (UTHealth) McGovern Medical School, 6431 Fannin St., MSB 5.020, Houston, Texas,

32

77030, U.S.A., E-mail: [email protected]

Corresponding Author: Carin A. Hagberg, MD

35

Office Phone: 713-792-5888 E-mail: [email protected]

36

Present Address:

37

The University of Texas MD Anderson Cancer Center

38

Division of Anesthesiology, Critical Care & Pain Medicine

39

1400 Holcombe Blvd., Unit 409

40

Houston, TX 77030

44 45 46 47 48 49 50 51

TE D

EP

43

Running (Short) Title: AirSPACE™ Technology in a Clinical Setting

AC C

42

M AN U

34

SC

Joseph C. Gabel Professor and Chair, Department of Anesthesiology, The University of Texas Health Science

33

41

RI PT

30

ACCEPTED MANUSCRIPT 3 ABSTRACT

53

Background: Patient positioning is critical in establishing an optimal laryngeal view during various airway

54

management techniques, including direct laryngoscopy. The “sniffing” position, in which all 3 axes are aligned,

55

has been the traditional method for direct laryngoscopy. [1, 2] The AirSPACE™ is a new positioning device that

56

was developed to facilitate patient positioning during laryngoscopy via mechanical head and neck manipulation,

57

potentially improving the visualization of laryngeal structures.

58

Aim: The purpose of this study was to evaluate the performance of the AirSPACE™ device, as measured by the

59

percentage of the Modified Cormack-Lehane (C-L) classification system, Grade’s III or IV specifically, for

60

glottic visualization during the first attempt of laryngoscopy and intubation.

61

Methods: Following IRB approval, 30 adult (≥18 y/o) patients with ASA status classifications I-III, requiring

62

tracheal intubation and general anesthesia participated in this study. In order to assess the performance of the

63

device, various measurements were obtained, including the initial C-L airway grade view during the first

64

attempt, the C-L grade view after repositioning (if necessary), the time required for patient repositioning, the

65

time required to obtain an optimal view of the glottis and CO2 detection, the time required to fully set up the

66

AirSPACE™ device onto the designated OR table, the number of attempts required for a successful intubation,

67

the minimum oxygen saturation (SpO2) while the airway was being secured, the method of laryngoscopy

68

performed, subjective assessment evaluations from utilizing the AirSPACE™, and safety reporting of any

69

adverse events.

70

Results: Of the 30 patients enrolled in the study, only 3 (10.0%, 95% confidence interval: 2.1%-26.5%) were

71

recorded with a C-L Grade III or IV, with an average repositioning time of 29.3 ± 8.4s. The frequency of initial

72

C-L grade views was: I, 50.0%; IIa, 16.7%; IIb, 23.3%; III, 6.7%; and IV, 3.3%. For the 3 patients who required

73

repositioning, 2 demonstrated improvement in the glottic view after repositioning, while one demonstrated no

74

improvement. The time required to obtain an optimal view of the glottis and that for CO2 detection was 19.7 ±

75

13.8s and 42.6 ± 22.0s, respectively. The average time required to set up the AirSPACE™ device was 4.29 ±

76

1.81 minutes. The average minimum oxygenation during intubation was 99.7 ± 0.6%. Direct laryngoscopy

77

(90%) was the preferred method when performing laryngoscopy and intubation, when compared to indirect

AC C

EP

TE D

M AN U

SC

RI PT

52

ACCEPTED MANUSCRIPT 4 (10%) during the study period. Nearly half of the laryngoscopists assessed the difficulty of laryngoscopy and

79

difficulty of ETT delivery as 1 (Very Easy), 43.3% and 46.7%, respectively, whereas 68.8% assessed

80

AirSPACE™ device ease of use as 1 (Very Easy).

81

Conclusion: This study, demonstrated that the AirSPACE™ device is an effective positioning mechanism that

82

provided the laryngoscopist with a highly favorable glottic view initially. Yet, further research is warranted in

83

evaluating the AirSPACE™’s effectiveness in improving glottic visualization of less favorable and more

84

difficult airways on a much larger spectrum.

RI PT

78

SC

85 86

Keywords: Airway management; airway equipment; laryngoscopy; tracheal intubation; patient positioning;

88

positioning device

AC C

EP

TE D

M AN U

87

ACCEPTED MANUSCRIPT 5 89

1. INTRODUCTION Laryngoscopy and tracheal intubation are performed on a regular basis when establishing an airway for

91

patients that undergo surgery. [1] Optimal visualization of laryngeal structures is essential in establishing a

92

patent airway for these patients; a greater glottic opening is inversely correlated with the number of intubation

93

attempts and the need for rescue intubation devices. [2] Fewer attempts at tracheal intubation result in less

94

trauma and fewer complications. [3] A poor view of the laryngeal structures increases the likelihood of a

95

difficult intubation. [4]

RI PT

90

SC

96

Patient positioning is critical in establishing optimal laryngeal view during laryngoscopy. An optimal

98

laryngeal view can be facilitated with proper head and neck positioning, including slight elevation of the head,

99

neck flexion relative to the chest, and extreme atlanto-occipital extension. [2] The “sniffing” position, used

100

traditionally for direct laryngoscopy, is achieved by neck flexion and head extension at the atlanto-occipital

101

joint. [2] However, a study by Adnet et al. reported that the sniffing position offers no advantage over simple

102

head extension, except in patients who are considered to be obese or have limited head extension. [3]

TE D

103

M AN U

97

In current clinical practice, the patient is typically placed in the sniffing position prior to laryngoscopy and

105

intubation by layering blankets and pillows underneath the patient’s back, shoulders, neck, and/or head, as

106

needed. However, these techniques can produce inconsistent positioning, may require additional resources and

107

additional time, and may be inconvenient for intra-operative changes during patient positioning and upon

108

removal of the positioning device(s) altogether. In morbidly obese patients, the “ramped” or head-elevated

109

laryngoscopy position (HELP), with the patient’s external auditory meatus horizontally aligned with the sternal

110

notch, is superior to the standard sniffing position. [2,3,5] Previous literature has reported the HELP position

111

being achieved by layering blankets or using pre-designed foam elevation pillows. [5,6] If traditional

112

positioning devices are used, they are customarily removed before the completion of the surgical procedure, and

113

therefore are not present during extubation. Current literature demonstrates variation in the standard practice of

114

head and neck positioning. [1-6] And as a result, a new positing device was invented with the intent to provide a

AC C

EP

104

ACCEPTED MANUSCRIPT 6 115

more consistent, faster, and possibly significant intraoperative manageability during laryngoscopy and

116

intubation.

117

The AirSPACE™ (Air Sniffing Position And Chin Elevation — Revolutionary Medical Devices, Inc., Tucson,

119

AZ, USA) is a positioning device which facilitates patient positioning by mechanically adjusting the patient’s

120

head into the sniffing position, thereby potentially improving the visualization of laryngeal structures during

121

laryngoscopy (Figure 1a). The purpose of this study was to evaluate the performance of the AirSPACE™ device

122

in optimizing and improving the view of the larynx during laryngoscopy, as measured by the percentage of the

123

Modified Cormack-Lehane (C-L) classification system (Grade’s III or IV) [7] during the first attempt of

124

laryngoscopy and intubation. Secondary objectives consisted of the average initial C-L grade view and/or

125

improvement in C-L Grade’s III or IV after device-assisted repositioning, the time required to place the patient

126

in optimal reverse Trendelenburg positioning, in conjunction with, successful placement of the endotracheal

127

tube (ETT) when using the AirSPACE™ device, the time required to obtain an optimal view and CO2 detection,

128

the time required to fully set up the AirSPACE™ device onto the designated OR table, the number of attempts

129

required for a successful intubation, the minimum oxygen saturation (SpO2) while the airway was being

130

secured, the method of laryngoscopy performed, subjective assessments pertaining to the difficulty of

131

laryngoscopy and intubation with the AirSPACE™, in addition to, the AirSPACE™’s ease-of-use. Also,

132

AirSPACE™ safety and tolerability were secondary objectives that consisted of technical performance indicated

133

by the incidence and nature of adverse events (AEs), serious adverse events (SAEs), unanticipated adverse

134

device effects (UADEs) and their duration, resolution and required treatment; if any.

136 137 138 139 140

SC

M AN U

TE D

EP

AC C

135

RI PT

118

ACCEPTED MANUSCRIPT 7 141

2. METHODS Following protocol approval by the Institutional Review Board (IRB) of the University of Texas Health

143

Science Center at Houston McGovern Medical School and the Research Committee of the Department of

144

Anesthesiology, 30 adult patients scheduled for elective surgery at Memorial Hermann Hospital – Texas

145

Medical Center were recruited to participate in this single site, non-randomized, open-label, single-group

146

volunteer study. Key research personnel, including the principal investigator, co-investigators, and/or study

147

coordinators obtained informed written consent.

RI PT

142

149

SC

148

2.1 Statistical Methods

Thirty human subjects were enrolled into this study. Assuming the percentage for C-L grade views III-IV is

151

20% [8], with this sample size, we expected to estimate this percentage with a precision level of 0.15 at 95%

152

confidence level. Descriptive statistics, the mean ± standard deviation (SD) for continuous variables and

153

frequency (percentage) for categorical variables, were used to summarize patient demographic, baseline clinical

154

characteristics, vital signs, and clinical performance variables. The percentage of repositioning needed during

155

laryngoscopy and intubation, as well as its 95% confidence interval, were calculated. All analyses were

156

performed using SAS 9.4 software (Cary, NC).

157 158

2.2 Patient Selection

EP

TE D

M AN U

150

The study group was comprised of individuals scheduled to undergo surgery that met the following inclusion

160

criteria: (1) age of 18 years old or older and (2) American Society of Anesthesiology (ASA) physical status I-

161

III. Exclusion criteria included the following: (1) < 18 years of age, (2) ASA physical status IV or V, (3)

162

presence of an underlying neuromuscular disease, (4) use of medications known to interfere with neuromuscular

163

transmission, (5) history of cervical spine injury or cervical pathology, (6) presence of renal or hepatic disease,

164

(7) presence of only one upper extremity, and (8) presence of open sores at the location(s) required for electrode

165

application.

166

AC C

159

ACCEPTED MANUSCRIPT 8 Cases involving surgical procedures, such as craniotomies and other invasive neurosurgical procedures that

168

require access to the patient’s head, including prone positioning; facial repairs and reconstructions; invasive

169

upper extremity involvement; and invasive airway management procedures were also excluded due to the

170

necessary access and manipulation of a patient’s head, and/or sterilization of a cephalic surgical field. The types

171

of surgical procedures that were included in this study were categorized into 3 specialties: urology, obstetrics

172

and gynecology (OBGYN), and general surgery (Supplementary Table 1).

173

RI PT

167

Morphometric characteristics such as neck circumference, inter-incisor gap, thyromental distance, and

175

sternomental distance were measured and recorded for all patients. The quality of each patient’s airway was

176

evaluated using the ASA Task Force’s physical examination recommendations according to the most recent

177

ASA Practice Guidelines for Management of the Difficult Airway. [9]

M AN U

SC

174

178 179

2.3 Study Procedure

Each patient received general anesthesia and endotracheal intubation. In the operating room (OR), standard

181

monitoring devices were applied, including a pulse oximeter, 3-lead electrocardiogram, and a non-invasive

182

blood pressure cuff. Measures of blood pressure (BP), heart rate (HR), respiratory rate (RR), oxygen saturation

183

(SpO2), and end-tidal carbon dioxide (EtCO2) were observed and recorded as a baseline (before the patient’s

184

surgical preparation and draping), and periodically throughout the perioperative period. Vital signs were

185

recorded immediately before oxygen administration, before induction of anesthesia, before ETT insertion,

186

during laryngoscopy, after ETT insertion, and postoperatively during the patient’s recovery in the post-

187

anesthesia care unit (PACU) as a precautionary measure during the study period. Study laryngoscopists

188

included resident, fellow, and attending anesthesiologists, anesthesiologist assistants, and medical students.

AC C

EP

TE D

180

189 190

Study personnel set up the AirSPACE™ device before each patient was brought into the OR. The initial step to

191

install the AirSPACE™ device was the removal of the existing headpiece of the operating table and storage.

192

Mounting hasps (clamps) were placed onto the rails of the operating table; the AirSPACE™ device was placed

ACCEPTED MANUSCRIPT 9 and arranged into the allotted holes of the mounting hasps, then securely tightened for stability (Figure 1b).

194

Once the device was secured, its electrical power cord was plugged into a standard 120 V outlet. Finally, the

195

disposable AirSPACE™ headrest and protection cover were attached to the headrest pins of the device and

196

arranged over the operating table (Figure 2). The time needed to set up the AirSPACE™ device was recorded in

197

each case.

RI PT

193

198

AirSPACE™ disposables include the single-use impermeable protective cover, for both the AirSPACE™

200

device and surgical table (if necessary), a disposable foam head donut (headrest), and a 15° head wedge as an

201

accessory (Figure 3). The integrated head wedge and donut are designed to provide comfort, proper head

202

positioning, and stability of the patient’s head during the administration of anesthetics, and even surgery. Both

203

pieces, the head wedge and donut, are removable; thus allowing the surgeon and/or anesthesiologist to move the

204

patient along the surgical table and reposition when desired.

M AN U

SC

199

205

Prior to induction, the patient’s head was aligned and stabilized onto the headrest of the AirSPACE™ device.

207

General anesthesia was induced by bolus administration of propofol (1.5 to 2 mg/kg) and fentanyl (1 mcg/kg)

208

and maintained with an inhalation agent. Rocuronium (0.6 mg/kg) was administered to induce muscle

209

relaxation. The lungs were mechanically ventilated to maintain an EtCO2 near 35 mmHg. Ventilation was

210

maintained via anesthesia full facemask with 100% oxygen administration until the patient was completely

211

relaxed (train of four on twitch monitor was 0).

EP

AC C

212

TE D

206

213

Each patient was placed in a neutral supine position prior to laryngoscopy and intubation. The laryngoscopist

214

performed either direct or indirect laryngoscopy. Patient repositioning with the AirSPACE™ device was

215

dependent on the initial C-L airway grade view obtained by the laryngoscopist. If the initial C-L airway grade

216

view observed was either III or IV, the patient was repositioned in an attempt to improve the glottic view via

217

neck flexion and head extension. Neck flexion was achieved by pressing the “head up/extension” or “head

218

down/flexion” button on the AirSPACE™ remote. The AirSPACE™ device uses a four-button pendant to control

ACCEPTED MANUSCRIPT 10 two linear actuators — one to raise and lower the head up and down (Figure 4a), and the other to increase or

220

decrease the angle of the head forward and backward (Figure 4b). Finally, a head-tilt, chin-lift, which is

221

manually controlled by using all four buttons on the remote, allows the patient’s head to slide into the desired

222

position along the slide rail of the head slide (Figure 4c). At the top of the head lift is the 15° head wedge and

223

headrest, which consists of a donut pad to provide head and neck comfort, along with proper spinal alignment

224

during anesthesia and surgery. The head slide and slide rail are designed to account for the difference between

225

the patient’s linkage (pivot points) and the AirSPACE™’s linkage (pivot points). With the operating table in

226

reverse Trendelenburg position, the device integrates 3 clinically recommended positions for airway

227

management: (1) sniffing position, (2) HELP, and/or (3) active head and neck positioning. The time needed to

228

perform laryngoscopy, the time needed to obtain an improved C-L airway grade view (via repositioning with

229

the AirSPACE™), and the time needed until the first CO2 waveform was observed, were all recorded.

M AN U

SC

RI PT

219

230

No more than 3 intubation attempts were allowed for each patient. The number of intubation attempts and

232

the minimum oxygen saturation during the entire airway procedure were recorded; oxygenation and ventilation

233

were both maintained until the airway was secured. If more than three attempts were needed, the intubation

234

procedure was deemed a device failure. After each successful intubation, the laryngoscopist was requested to

235

assess the following: difficulty of laryngoscopy, difficulty of ETT delivery, adequacy of laryngeal view during

236

passage of ETT, and AirSPACE™ ease-of-use. These subjective assessments were recorded via numerical rating

237

scale that corresponded to a described degree of difficulty. By this scale, 1 = Very Easy and 5 = Not Possible,

238

thereby representing the level of difficulty perceived by the laryngoscopist when they successfully secured the

239

airway. [9] The AirSPACE™ device ease-of-use was represented by a classified rating scale, ranging from a

240

Grade 0 = Very Easy to Grade 4 = Failed (Supplementary Table 2). If a successful intubation attempt was not

241

achieved by the third attempt, the patient's airway was secured using an alternative method/device for tracheal

242

intubation.

243 244

AC C

EP

TE D

231

ACCEPTED MANUSCRIPT 11 245

3. RESULTS

246

3.1 Repositioning with the AirSPACE™ The summary statistics of demographics, baseline morphometric characteristics, and anesthetist levels are

248

reported in Table 1. Of the 30 patients enrolled in this study, only 3 (10.0%, 95% confidence interval: 2.1%-

249

26.5%) were recorded with having an initial C-L grade of III or IV, with an average repositioning time of 29.3 ±

250

8.4s. Therefore, 27 patients (90%) were classified with having an initial C-L grade view of I, IIa, or IIb. For the

251

3 patients that had an initial C-L grade view of III or IV and were repositioned per protocol, 2 (66.7%) had an

252

improvement in the glottic view after repositioning with the AirSPACE™ device, and only one (33.3%) showed

253

no improvement. The distribution of initial C-L grade views for all 30 patients was: Grade I, 15; Grade IIa, 5;

254

Grade IIb, 7, Grade III, 2; and Grade IV, 1 (Figure 5).

M AN U

SC

RI PT

247

255

Although only 3 patients needed repositioning per protocol, 7 patients were repositioned due to the

257

laryngoscopist’s concern and interest of the AirSPACE™’s capabilities, even though a favorable glottic view

258

was obtained initially. For these 7 patients that were repositioned, due to the laryngoscopist’s curiosity, 6

259

(85.7%) had an improvement in the glottic view, while one (14.3%) showed no improvement. The average

260

repositioning time for these 7 patients was 20.1 ± 12.0s. Of the 10 patients that were repositioned overall, 8 had

261

an improvement in the C-L grade view (80%) and 2 demonstrated no improvement (20%). The average

262

repositioning time for all 10 patients was 22.8 ± 11.4s. Ultimately, no patient demonstrated a decrease in the

263

glottic view when repositioning was desired (Table 2).

AC C

EP

TE D

256

264 265

3.3 Intubation Attempt(s) Required

266

Twenty-four of the 30 patients (80.0%) were intubated during the first attempt by the laryngoscopist. More

267

than one intubation attempt was required for 6 patients (20%), with only one of the 6 patients requiring > 2

268

attempts.

269 270

3.4 Oxygen Saturation During Laryngoscopy and Intubation

ACCEPTED MANUSCRIPT 12 The average minimum SpO2 during intubation was 99.7 ± 0.6% for all 30 patients. The lowest recorded

272

SpO2 during the airway procedure was 98% (three patients), and the highest was 100% (25 patients). Only two

273

patients were recorded as having an oxygen saturation of 99%; further details pertaining to oxygen saturation

274

during the entire airway procedure for all 30 patients are presented in Table 3.

275 276

3.5 Laryngoscopy and Intubation with the AirSPACE™

RI PT

271

During the study period, 90% of the patients were intubated via direct laryngoscopy and 10% via indirect.

278

The times required to obtain an optimal view and for CO2 detection for all 30 patients were 19.7 ± 13.8s and

279

42.6 ± 22.0s, respectively. Twenty-nine of the 30 patients were successfully intubated with the AirSPACE™

280

device (Table 4).

281 282

3.6 Subjective Assessment for Level of Difficulty

M AN U

SC

277

The laryngoscopists were requested to evaluate, via a numerical rating scale, the level of difficulty during the

284

entire airway procedure using the AirSPACE™ device. Nearly half of the laryngoscopists assessed the difficulty

285

of laryngoscopy and difficulty of ETT delivery as 1 (Very Easy), 43.3% and 46.7%, respectively; whereas

286

68.8% assessed the AirSPACE™’s ease-of-use as Grade 1 (Somewhat Easy). Further details regarding

287

laryngoscopist’s assessments are reported in Table 5.

EP

TE D

283

288

290 291 292 293 294 295 296

3.7 Safety Reporting

AC C

289

There were no AEs, SAEs, or UADEs associated with the use of the AirSPACE™ device during the study period.

ACCEPTED MANUSCRIPT 13 297

4. DISCUSSION This study demonstrated that the AirSPACE™ device provides sufficient, initial, patient positioning, paired

299

with a desirable glottic view, for 27 of the 30 patients (90%). It is an effective positioning mechanism that

300

provided the laryngoscopist with a noticeable improvement in the glottic view via instantaneous airway

301

manipulation (head repositioning) during laryngoscopy for 2 of the 3 patients that received an initial C-L grade

302

view of III or IV. Although we reported the results of 7 patients that were repositioned, not based on protocol

303

procedures, the end result of improving and optimizing such favorable C-L grade views, such as a IIa or IIb,

304

adds value towards the purpose and intent of the AirSPACE™ device.

SC

RI PT

298

305

Difficult laryngoscopy usually results from poor glottic visualization, and is, therefore, linked to the likelihood

307

of a difficult intubation. [10] Correct positioning of the patient appears to be the main determining factor for

308

obtaining good glottic visualization under direct laryngoscopy, including the use of the sniffing position. [11]

309

Twelve of the 30 patients (40%) in this study had a body mass index (BMI) > 30 kg/m2, while the remaining 18

310

patients (60%) had a BMI < 30 kg/m2. Of the 12 patients with a BMI > 30 kg/m2, only one patient (8.3%) was

311

repositioned because of an initial C-L grade view of III that ultimately improved to a Grade I, therefore

312

allowing a successful intubation on the first attempt. The other 11 patients (91.7%) had such a favorable initial

313

C-L grade view that repositioning was unnecessary, and these patients were all successfully intubated during the

314

first attempt. The AirSPACE™ device, along with reverse Trendelenburg orientation, is designed to help

315

patients at risk for difficulties in mask ventilation, direct laryngoscopy, and tracheal intubation. [12]

TE D

EP

AC C

316

M AN U

306

317

The methods of laryngoscopy used in this study are typical of the institution’s practice and were completely

318

based on the anesthesiologist’s discretion and care plan. Thus, there is no preference for which laryngoscope or

319

which method of laryngoscopy that should be paired with the use of the AirSPACE™ device while the airway is

320

secured. The decision was made not to standardize the type of laryngoscope in order to illustrate the

321

AirSPACE™’s capabilities with both direct and indirect methods.

322

ACCEPTED MANUSCRIPT 14 During our postoperative observations and assessments in the post-anesthesia care unit, no patient reported

324

head or neck discomfort (or any related issues), even though the surgical procedures ranged in duration from 2-

325

5 hours. This suggests that the AirSPACE™ device is able to effectively support a patient’s head for extensive

326

surgical procedures, even during lateral positioning.

RI PT

323

327

4.1 Limitations

329

This study has several limitations. First, there was no standardization during repositioning of either the

330

operating table or the AirSPACE™ device. The angle at which the operating table was set during repositioning

331

into reverse Trendelenburg orientation was not measured, nor was the height and the angle of manipulation of

332

the AirSPACE™ device itself. Furthermore, the number of study personnel required to install the AirSPACE™

333

device onto the operating table was observed, but not recorded. Nonetheless, the AirSPACE™ device can be

334

installed onto an OR table within 2 - 4 minutes by two people, and within 3 - 5 minutes by one person (this

335

estimation is based on the data collected as part of Section 2.2 Study Procedure). Although there are no reports

336

of the time required for patient positioning with other elevating apparatuses such as blankets, ramps, and

337

pillows, further research is warranted to identify differences between the AirSPACE™ and standard elevating

338

devices in average C-L view grade (along with improvement in view grade if necessary) in obese patients, first

339

attempt intubation success rate, time required for patient repositioning, and assess economic considerations. The

340

various skill levels of the laryngoscopists that were included in the study were not standardized as well, due to

341

AirSPACE™’s simplistic and novel capabilities. For that reason, we can surmise using the AirSPACE™ as a

342

teaching tool for students (medical, AA, CRNA) and/or less skilled anesthesia practitioners during

343

laryngoscopy and tracheal intubation. As the experience level of the laryngoscopist varied, the overall 80%

344

success rate for glottic view improvement and initial intubation with the AirSPACE™ could be attributed to the

345

skill level of the laryngoscopist and/or operator error due to limited familiarity and capability with the device.

346

Since there were only 3 patients with a C-L grade view of III or IV, our data is limited in performing a subgroup

347

analysis in order to identify which predictors of a difficult intubation were associated between the 2 groups. In

348

addition to, the requirement for more than one intubation attempt.

AC C

EP

TE D

M AN U

SC

328

ACCEPTED MANUSCRIPT 15 349

5. CONCLUSION Appropriate patient positioning increases the likelihood of a successful laryngoscopy and tracheal

351

intubation.[13] Although the sniffing position is commonly performed to improve laryngeal view during direct

352

laryngoscopy, patients in this study were initially placed in a neutral, supine position during laryngoscopy until

353

further movement was deemed necessary. The AirSPACE™ provided easy, ‘real-time’, mechanical airway

354

manipulation during laryngoscopy whenever repositioning was necessitated, and therefore increased the

355

likelihood of a successful tracheal intubation on the first attempt.

SC

356

RI PT

350

Initial patient positioning with the AirSPACE™ device was sufficiently accurate in 27 of the 30 patients

358

(90.0%). Overall, the AirSPACE™ device provided adequate positioning and improved the glottic view for 2 of

359

the 3 patients (66.7%) that had an initial C-L grade view of III or IV. This study, demonstrated that the

360

AirSPACE™ device is an effective positioning mechanism that provided the laryngoscopist with a highly

361

favorable glottic view initially; yet, further research is warranted in evaluating the AirSPACE™’s effectiveness

362

in improving glottic visualization of less favorable and more difficult airways on a much larger spectrum.

366 367 368 369 370 371 372

TE D

365

EP

364

AC C

363

M AN U

357

ACCEPTED MANUSCRIPT 16 373

Acknowledgement: Dr. Cai's research was supported by a National Institutes of Health Clinical and

374

Translational Science Award grant (UL1 TR000371), awarded to the University of Texas Health Science Center

375

at Houston in 2012 by the National Center for Clinical and Translational Sciences.

RI PT

376 377

Disclosures (Conflict of Interest): Dr. Hagberg has financial relationships with Ambu, Cadence

378

Pharmaceuticals, Karl Storz Endoscopy, and MedCom Flow in the form of funded research, and is an unpaid

379

consultant for Ambu, Covidien, and SonarMed.

SC

380

Funding Source: This work was supported by Revolutionary Medical Devices, Inc., in conjunction with

382

Covidien-Medtronic.

AC C

EP

TE D

M AN U

381

ACCEPTED MANUSCRIPT 17 REFERENCES

384

[1] Sainsbury JE, Telgarsky B, Parotto M, Niazi A, Wong DT, Cooper RM. The effect of verbal and video

385

feedback on learning direct laryngoscopy among novice laryngoscopists: a randomized pilot study.

386

Canadian Journal of Anesthesia. 2016. 1-8.

RI PT

383

387

[2] Levitan RM, Mechem CC, Ochroch EA, Shofer FS, Hollander JE. Head-elevated laryngoscopy position:

388

improving laryngeal exposure during laryngoscopy by increasing head elevation. Annals of Emergency

389

Medicine. 2003. 41(3):322-30.

[3] Adnet F, Baillard C, Borron SW, Denantes C, Lefebvre L, Galinski M, Martinez C, Cupa M, Lapostolle F.

391

Randomized study comparing the “sniffing position” with simple head extension for laryngoscopic view in

392

elective surgery patients. The Journal of the American Society of Anesthesiologists. 2001. 95(4):836-41.

393

[4] Mort TC. Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts.

396 397 398

M AN U

395

Anesth Analg. 2004. 99(2):607-13.

[5] Benumof JL. Difficult laryngoscopy: obtaining the best view. Canadian Journal of Anesthesia. 1994. 41(5):361-5.

TE D

394

SC

390

[6] Rich JM. Use of an elevation pillow to produce the head-elevated laryngoscopy position for airway management in morbidly obese and large-framed patients. Anesth Analg. 2004. 98(1):264-5. [7] Shiga T, Wajima ZI, Inoue T, Sakamoto A. Predicting difficult intubation in apparently normal patients: a

400

meta-analysis of bedside screening test performance. The Journal of the American Society of

401

Anesthesiologists. 2005. 103(2):429-37.

403

AC C

402

EP

399

[8] Krage R, Van Rijn C, Van Groeningen D, Loer SA, Schwarte LA, Schober P. Cormack–Lehane classification revisited. British journal of anaesthesia. 2010 Jun 16:aeq136.

404

[9] Apfelbaum JL, Hagberg CA, Caplan RA, Blitt CD, Connis RT, Nickinovich DG, et al. Practice Guidelines

405

for Management of the Difficult Airway: An Updated Report by the American Society of Anesthesiologists

406

Task Force on Management of the Difficult Airway. The Journal of the American Society of

407

Anesthesiologists. 2013. 118(2):251-70.

ACCEPTED MANUSCRIPT 18 408

[10] Vijayakumar V, Rao S, Shetty N. A comparison of Macintosh and Airtraq laryngoscopes for endotracheal intubation in adult patients with cervical spine immobilization using manual in line axial

410

stabilization: a prospective randomized study. Journal of Neurosurgical Anesthesiology. 2016. 28(4):296-

411

302.

RI PT

409

412

[11] Prakash S, Kumar A, Bhandari S, Mullick P, Singh R, Gogia AR. Difficult laryngoscopy and intubation in

413

the Indian population: An assessment of anatomical and clinical risk factors. Indian Journal of Anesthesia.

414

2013. 57(6):569-75.

416

[12] Reddy RM, Adke M, Patil P, Kosheleva I, Ridley S. Comparison of glottic views and intubation times in

SC

415

the supine and 25 degree back-up positions. BMC Anesthesiology. 2016. 16(1):113. [13] Cattano D, Melnikov V, Khalil Y, Sridhar S, Hagberg CA. An evaluation of the rapid airway management

418

positioner in obese patients undergoing gastric bypass or laparoscopic gastric banding surgery. Obesity

419

surgery. 2010. 20(10):1436-41.

M AN U

417

[14] Frerk C, Mitchell VS, McNarry AF, Mendonca C, Bhagrath R, Patel A, et al. Difficult Airway Society

421

2015 guidelines for management of unanticipated difficult intubation in adults. British Journal of

422

Anesthesia. 2015. 115(6):827-48.

AC C

EP

TE D

420

ACCEPTED MANUSCRIPT Table 1. Summary statistics of demographics, baseline morphometric characteristics, and anesthetist levels.

Total (n=30) 51.4±17.2 29.9±5.7

RI PT

18 (60.0) 12 (40.0) 19 (63.3) 11 (36.7) 4.6±0.9 5.6±1.6 13.5±2.2

SC

Demographics Age, years, mean±SD BMI, kg/m2, mean±SD BMI >30 kg/m2, n (%) No Yes Sex, n (%) Female Male Inter-incisor gap distance, cm, mean±SD Thyromental distance, cm, mean±SD Sternomental distance, cm, mean±SD Mallampati classification, n (%) 1 2 3 Anesthetist level, n (%) AA Attending CA-1 CA-2 CA-3 Fellow Medical student

TE D

M AN U

14 (46.7) 14 (46.7) 2 (6.7)

14 (46.7) 2 (6.7) 6 (20.0) 2 (6.7) 2 (6.7) 2 (6.7) 2 (6.7)

AC C

resident-year.

EP

BMI, body mass index; SD, standard deviation; AA, anesthesiologist assistant; CA-1, 2, 3, clinical anesthesia

ACCEPTED MANUSCRIPT Table 2. Recorded C-L airway grade views during laryngoscopy when repositioned with the AirSPACE™.

C-L Grade View Before/After Repositioning with AirSPACE™ (n)

Direct

8

IIa/IIa (1) IIb/I (3) IIb/IIa (2) III/IIa (1) IV/IV (1)

Indirect

2

IIa/I (1) III/I (1)

AC C

EP

TE D

M AN U

SC

RI PT

No. of Patients

Laryngoscopy Method

ACCEPTED MANUSCRIPT Table 3. Recorded vitals for all 30 patients during induction and laryngoscopy with the AirSPACE™.

Vital Signs

Total (n=30)

Preoxygenation HR, n

74.4±12.4

Preoxygenation Systolic BP, n mean±SD

137.2±16.1

Preoxygenation Diastolic BP, n

80.5±14.9

Preoxygenation RR, n mean±SD

Preinduction Systolic BP, n mean±SD

Preinduction Diastolic BP, n

TE D

mean±SD

Preinduction RR, n mean±SD

Preinduction SpO2, n

EP

mean±SD

Preinduction EtCO2, n

AC C

mean±SD

Pre-ETT Insertion HR, n mean±SD

Pre-ETT Insertion Systolic BP, n mean±SD

Pre-ETT Insertion Diastolic BP, n mean±SD Pre-ETT Insertion RR, n mean±SD Pre-ETT Insertion SpO2, n mean±SD

25

98.7±1.8

M AN U

mean±SD

2

8.5±7.8

Preoxygenation SpO2, n Preinduction HR, n

21

SC

mean±SD

mean±SD

21

RI PT

mean±SD

26

30

71.1±12.6 29

136.3±14.2 29

80.0±14.4 23 8.9±3.9 30 99.6±1.2 26 29.8±8.6 30 77.0±12.3 30 132.7±18.6 30 77.8±13.1 30 11.7±5.7 30 100.0±0.2

ACCEPTED MANUSCRIPT Vital Signs

Total (n=30)

Pre-ETT Insertion EtCO2, n mean±SD

29 26.4±8.4

Post-ETT Delivery HR, n mean±SD

30 84.3±13.1

mean±SD

122.1±25.3

Post-ETT Delivery Diastolic BP, n mean±SD

11.6±2.3

Post-ETT Delivery SpO2, n

96.7±16.4

Post-ETT Delivery EtCO2, n

PACU Systolic BP, n

TE D

mean±SD

PACU Diastolic BP, n mean±SD

30

38.4±5.8 30

71.1±12.7 30

126.2±14.2 30 71.1±10.4 30 17.7±6.8

PACU SpO2, n

30

mean±SD

98.1±4.2

AC C

mean±SD

EP

PACU RR, n

30

M AN U

mean±SD

mean±SD

30

SC

mean±SD

PACU HR, n

28

77.1±15.8

Post-ETT Delivery RR, n

mean±SD

28

RI PT

Post-ETT Delivery Systolic BP, n

SD, standard deviation; BP, blood pressure; ETT, endotracheal tube; PACU, post-anesthesia care unit.

ACCEPTED MANUSCRIPT Table 4. Time required for laryngoscopy and intubation with the AirSPACE™.

No. of Patients

Action

Mean Duration ± SD, seconds

Direct

27 26 26

Time for optimal view Time for first CO2 waveform Total intubation time

17.9 ± 12.6 41.0 ± 22.5 58.8 ± 30.1

Indirect

3 3 3

Time for optimal view Time for first CO2 waveform Total intubation time

36.2 ± 16.1 56.6 ± 10.9 92.8 ± 9.3

AC C

EP

TE D

M AN U

SC

RI PT

Laryngoscopy Method

ACCEPTED MANUSCRIPT Table 5. Numerical rating scale scores and subjective assessments after utilizing the AirSPACE™.

14 (46.7) 13 (43.3) 2 (6.7) 0 (0) 1 (3.3)

SC

13 (43.3) 11 (36.7) 5 (16.7) 0 (0) 1 (3.3)

M AN U

Difficulty of Laryngoscopy (n=30) 1=Very Easy 2=Easy 3=Slight Resistance 4=Difficult 5=Not Possible Difficulty of Intubation (n=30) 1=Very Easy 2=Easy 3=Slight Resistance 4=Difficult 5=Not Possible AirSPACE™ Device Ease of Use (n=30) 0=Very Easy 1=Somewhat Easy 2=Somewhat Difficult 3=Very Difficult 4=Failed Laryngeal View during Passage of ETT (n=30) Complete Partial Obstructed

RI PT

Frequency, n (%)

Type of Airway Procedure

22 (73.3) 7 (23.3) 1 (3.4)

TE D

AC C

EP

ETT, endotracheal tube.

5 (16.7) 21 (70.0) 3 (10.0) 0 (0) 1 (3.3)

ACCEPTED MANUSCRIPT

SC

RI PT

Figure 1. The AirSPACE™.

M AN U

(a) The AirSPACE™.

AC C

EP

TE D

(b) The AirSPACE™ installed and attached onto a surgical table.

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

Figure 2. Fully assembled AirSPACE™ along with disposable surgical table cover and patient headrest.

ACCEPTED MANUSCRIPT Figure 3. AirSPACE™ disposables – (1) foam head donut (headrest), (2) 15° head wedge, and (3) impermeable

AC C

EP

TE D

M AN U

SC

RI PT

protective cover (for both the AirSPACE™ device and surgical table).

ACCEPTED MANUSCRIPT

SC

RI PT

Figure 4. Mechanical movement and operation of the AirSPACE™ device.

The AirSPACE™ device, in a raised position, via fourbutton pendant remote that controls two actuators; one actuator raises and lowers the head lift (shown).

The AirSPACE™ device being angled via four-button pendant remote that controls two actuators; one actuator increases or decreases the angle of the headrest/headlift (shown).

AC C

EP

TE D

M AN U

(a)

(b)

(c)

The head slide (black platform with lever and headrest pins) and slide rail of the AirSPACE™ device in the unlocked position; providing easy and smooth flexion and extension of the patient's head during laryngoscopy.

ACCEPTED MANUSCRIPT Figure 5. Initial C-L airway grade views when comparing laryngoscopy (direct versus indirect).

Initial C-L Airway Grade Views with Direct or Indirect Laryngoscopy 16 Direct 14

RI PT

10 8 6

SC

4 2 I (50%)

IIa (16.67%)

M AN U

0 IIb (23.33%)

III (6.67%)

EP

TE D

Initial C-L Airway View Grade

AC C

Number of Patients

Indirect

12

IV (3.33%)

ACCEPTED MANUSCRIPT Highlights Patient positioning is critical in establishing a patent airway



Proper head and neck positioning can optimize one’s laryngeal view



The “sniffing” position has been the traditional method for direct laryngoscopy



The AirSPACE™ device facilitates patient positioning via mechanical capabilities



The AirSPACE™ device provides ‘real-time’ airway manipulation during laryngoscopy

AC C

EP

TE D

M AN U

SC

RI PT